These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 22495954)
1. Why change injection sites for depot antipsychotic medication? Cox A; Emmerson B; Collyer B; Scott J Aust N Z J Psychiatry; 2012 Aug; 46(8):794. PubMed ID: 22495954 [No Abstract] [Full Text] [Related]
2. Injection of depot antipsychotic medications in patients with schizophrenia. Fleishman M J Clin Psychiatry; 2002 Sep; 63(9):840-1; author reply 841-2. PubMed ID: 12363128 [No Abstract] [Full Text] [Related]
3. A comparison of two depot injection techniques. Mac Gabhann L Nurs Stand; 1998 Jun 3-9; 12(37):39-41. PubMed ID: 9732632 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of depot injection techniques. Quartermaine S; Taylor R Nurs Times; 1995 Jul 26-Aug 1; 91(30):36-9. PubMed ID: 7644369 [TBL] [Abstract][Full Text] [Related]
5. Improvements in nursing practice through a study comparing intramuscular depot injection administration techniques. MacGabhann L J Psychiatr Ment Health Nurs; 1997 Dec; 4(6):436-7. PubMed ID: 9505639 [No Abstract] [Full Text] [Related]
6. Long-acting neuroleptics: technique for intramuscular injection. Bélanger-Annable MC Can Nurse; 1985 Sep; 81(8):41-3. PubMed ID: 2862986 [No Abstract] [Full Text] [Related]
7. [Technics for intramuscular injections of delayed-action neuroleptics]. Bélanger-Annable MC Infirm Can; 1985 Sep; 27(8):26-9. PubMed ID: 2863219 [No Abstract] [Full Text] [Related]
9. Why are Canadians complacent about long-acting injectable antipsychotic therapies? Come on, Canada, you can do better! Weiden PJ Can J Psychiatry; 2013 May; 58(5 Suppl 1):3S-4S. PubMed ID: 23945066 [No Abstract] [Full Text] [Related]
10. Is depot medication safe in the setting of myopathy? Price JR; Bastiampillai T; Dhillon RS Aust N Z J Psychiatry; 2009 Aug; 43(8):781-3. PubMed ID: 19629801 [No Abstract] [Full Text] [Related]
11. The subjective experiences of people who regularly receive depot neuroleptic medication in the community. Phillips L; McCann E J Psychiatr Ment Health Nurs; 2007 Sep; 14(6):578-86. PubMed ID: 17718731 [TBL] [Abstract][Full Text] [Related]
16. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia. Johnson DA J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743 [TBL] [Abstract][Full Text] [Related]
17. Datapoints: depot antipsychotic use in New York State hospitals, 1994 to 2009. Citrome L; Jaffe A; Levine J Psychiatr Serv; 2010 Jan; 61(1):9. PubMed ID: 20044411 [No Abstract] [Full Text] [Related]
18. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety. Hawley C; Turner M; Latif MA; Curtis V; Saleem PT; Wilton K Hum Psychopharmacol; 2010 Jan; 25(1):37-46. PubMed ID: 20041474 [TBL] [Abstract][Full Text] [Related]
19. [Depot antipsychotics in the year 2011]. Knegtering H; Oolders H; Ruijsink MA; van der Moolen AE Tijdschr Psychiatr; 2011; 53(2):95-105. PubMed ID: 21319066 [TBL] [Abstract][Full Text] [Related]
20. Indiscriminate use of intramuscular injections: An unforeseen public health hazard. Kumar A; Garozzo D; Shukla DP Neurol India; 2019; 67(Supplement):S92-S93. PubMed ID: 30688240 [No Abstract] [Full Text] [Related] [Next] [New Search]